Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schenk

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Unfallheilkunde|May 1, 1980
[Cortical revascularization after medullary nailing in dog tibiae (author's transl)]F Eitel, R K Schenk, L Schweiberer
European Heart Journal|February 1, 1983
Electrocardiographic features at onset of ventricular fibrillation in acute myocardial infarction. Relation to intraventricular conduction defects, configuration of initiating QRS complex, preceding heart rate and initiating coupling intervalL Mogensen, E Orinius, K Schenk-Gustafsson
Canadian Anaesthetists' Society Journal|May 1, 1983
Naloxone reverses the hypnotic effect and the depressed baroreceptor reflex of halothane anaesthesia in the dogE Freye, E Hartung, G K Schenk
Pharmacology|January 1, 1983
Effects of three narcotic antagonists (naltrexone, diprenorphine, and S-20682) on blood pressure, heart rate and electrical cortical activityE Freye, E Hartung, G K Schenk
Functional Neurology|July 1, 1987
Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dogE Freye, R Buhl, G K Schenk
Anesthesia and Analgesia|May 1, 1983
Bremazocine: an opiate that induces sedation and analgesia without respiratory depressionE Freye, E Hartung, G K Schenk
Pharmacology|January 1, 1982
Perfusion of the fourth cerebral ventricle with the synthetic opioid peptide, FK 33-824, induces dose-related bradycardia and naloxone-reversible respiratory depression in the awake dogE Freye, E Hartung, G K Schenk
Life Sciences|January 1, 1983
Tifluadom (KC 5103) induces suppression and latency changes on somatosensory evoked potentials which are reversed by opioid antagonistsE Freye, E Hartung, G K Schenk
EEG-EMG Zeitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete|September 1, 1982
[Naloxone-resistant EEG slowing induced by the synthetic opioid peptide FK 33-824 in the 4th cerebral ventricle of the dog]E Freye, G K Schenk, E Hartung
Aviation, Space, and Environmental Medicine|November 1, 1981
Beta-receptor blocking therapy in hypertensive patients--effects on vigilance and behaviourG K Schenk, E Lang, M Anlauf
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Unfallheilkunde|May 1, 1980
[Cortical revascularization after medullary nailing in dog tibiae (author's transl)]F Eitel, R K Schenk, L Schweiberer
European Heart Journal|February 1, 1983
Electrocardiographic features at onset of ventricular fibrillation in acute myocardial infarction. Relation to intraventricular conduction defects, configuration of initiating QRS complex, preceding heart rate and initiating coupling intervalL Mogensen, E Orinius, K Schenk-Gustafsson
Canadian Anaesthetists' Society Journal|May 1, 1983
Naloxone reverses the hypnotic effect and the depressed baroreceptor reflex of halothane anaesthesia in the dogE Freye, E Hartung, G K Schenk
Pharmacology|January 1, 1983
Effects of three narcotic antagonists (naltrexone, diprenorphine, and S-20682) on blood pressure, heart rate and electrical cortical activityE Freye, E Hartung, G K Schenk
Functional Neurology|July 1, 1987
Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dogE Freye, R Buhl, G K Schenk
Anesthesia and Analgesia|May 1, 1983
Bremazocine: an opiate that induces sedation and analgesia without respiratory depressionE Freye, E Hartung, G K Schenk
Pharmacology|January 1, 1982
Perfusion of the fourth cerebral ventricle with the synthetic opioid peptide, FK 33-824, induces dose-related bradycardia and naloxone-reversible respiratory depression in the awake dogE Freye, E Hartung, G K Schenk
Life Sciences|January 1, 1983
Tifluadom (KC 5103) induces suppression and latency changes on somatosensory evoked potentials which are reversed by opioid antagonistsE Freye, E Hartung, G K Schenk
EEG-EMG Zeitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete|September 1, 1982
[Naloxone-resistant EEG slowing induced by the synthetic opioid peptide FK 33-824 in the 4th cerebral ventricle of the dog]E Freye, G K Schenk, E Hartung
Aviation, Space, and Environmental Medicine|November 1, 1981
Beta-receptor blocking therapy in hypertensive patients--effects on vigilance and behaviourG K Schenk, E Lang, M Anlauf
Pageof 16